[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.213.148. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
October 1999

Methotrexate as an Adjuvant Treatment for Pemphigus Vulgaris

Author Affiliations

Not Available

Arch Dermatol. 1999;135(10):1275-1276. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-10-dlt1099

Conventional adjuvant treatments do not consistently permit steroid therapy to be discontinued in patients with chronic pemphigus vulgaris (PV).1,2 Methotrexate therapy, which was reported to be effective,3,4 has been largely abandoned because of concerns about toxic effects.1,2 This might have resulted from the high dosages (up to 150 mg/wk) of methotrexate used together with high dosages of steroids. We describe the efficacy of low dosages of methotrexate in patients taking low to moderate dosages of steroids.

First Page Preview View Large
First page PDF preview
First page PDF preview
×